Enhanced glomerular expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy

Nephrology Dialysis Transplantation

Volumn 13, Issue 5, 1998, Pages 1168-1175

  Ando, Yutaka ^b   Moriyama, Toshiki ^b   Miyazaki, Mutsuo ^b   Akagi, Yoshitaka ^b   Kawada, Noritaka ^b   Isaka, Yoshitaka ^b   Izumi, Masaaki ^b   Yokoyama, Kenji ^b   Yamauchi, Atsushi ^b   Horio, Masaru ^b   Ando, Akio ^b   Ueda, Naohiko ^b   Sobue, Kenji ^b   Imai, Enyu ^a   Hori, Masatsugu ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Caldesmon; Glucocorticoid heparin therapy; IgA nephropathy; Mesangial cell; Phenotypic change

Indexed keywords

ACTIN ANTIBODY; CALDESMON; GLUCOCORTICOID; HEPARIN; PROTEIN ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MESANGIUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SMOOTH MUSCLE FIBER;

ACTINS; CALMODULIN-BINDING PROTEINS; DRUG THERAPY, COMBINATION; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HEPARIN; HUMANS; KIDNEY GLOMERULUS; MUSCLE, SMOOTH; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 7144257851     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.5.1168     Document Type: Article

References (20)

1. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int 1992; 41: 1134-1142
2. Kishino M, Kimura A, Yamaguchi K et al. Increased expression of a brain/embryo-type myosin heavy chain isoform (MIIB2) in mesangial proliferative glomerulonephritis. Kidney Int 1996; 49: 1350-1359
3. Becker CG. Demonstration of actomyosin in mesangial cells of the renal glomerulus. Am J Pathol 1972; 66: 97-110
4. Ausiello DA, Kreisberg JI, Roy C, Karnovsky JI. Contraction of rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 1980; 65: 754-759
5. Sobue K, Marumoto Y, Fujita M, Kakiuchi S. Purification of a calmodulin-binding protein from chickengizzard that interacts with F-actin. Proc Natl Acad Sci USA 1981; 78: 5652-5655
6. Sobue K, Sellers JR. Caldesmon, a novel regulatory protein in smooth muscle and non muscle actomyosin system. J Biol Chem 1991; 266: 12115-12118
7. Ueki N, Sobue K, Kanda K, Hada K, Higashino K. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 1987; 84: 9049-9053
8. Glukhova MA, Kabakov AE, Frid MG et al. Modulation of human aorta smooth muscle cell phenotype. A study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 1988; 85: 9542-9546
9. Ishino T, Kobayashi R, Wakui H et al. Biochemical characterization of contractile proteins of rat cultured mesangial cells. Kidney Int 1991; 39: 1118-1124
10. Hiroi J, Kimura K, Aikawa M et al. Expression of a nonmuscle myosin heavy chain in glomerular cells differentiates various types of glomerular disease in rats. Kidney Int 1996; 49: 1231-1241
11. Fujiwara Y, Orita Y, Sasaki E, Abe H, Takamitu Y. Influence of mesangial proliferation on posturally induced change in glomerular filtration rate. Nephron 1983; 35: 35-38
12. Yamashiro S, Yamakita Y, Hosoya H, Matsumura F. Phosphorylation of non-muscle caldesmon by p34cdc kinase during mitosis. Nature 1991; 349: 169-172
13. Birukov KG, Shirinsky VP, Stepanova OV et al. Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem 1995; 144: 131-139
14. Kriz W, Elger M, Lemley K, Sakai T. Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int 1990; 38 [Suppl.] 30: S-2-S-9
15. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy: a 10-year follow up study. Nephron 1996; 72: 237-242
16. Tateno S, Kobayashi Y. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy. Nephron 1987; 46: 28-33
17. Yoshikawa N, Itoh H, Japanese Pediatric IgA Nephropathy Treatment Study Group. A controlled trial of prednisolone (P), azathioprine (A), heparin-warfarin (H-W) and dipyridamole (D) in newly diagnosed severe childhood IgA nephropathy (IGAN). J Am Soc Nephrol 1996; 7: 1401
18. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993; 43: 369-380
19. Yano H, Hayashi T, Momiyama H et al. Transcriptional regulation of the chicken caldesmon gene. J Biol Chem 1995; 270: 23661-23666
20. Blank RS, McQuinn TC, Yin KC et al. Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. J Biol Chem 1992; 267: 984-989